Child Sacrifice: The FDA Approved Remdesivir Based on a Trial in Which 3 out of 53 Children Died

The trial was conducted by Gilead, the developer of remdesivir, and there was no control group.

The mortality rate of children with no treatment against COVID is 0.005% (1 in 20,000 die).

Based on this trial, the mortality rate of children with remdesivir treatment is 5.66% (1 in 17.7 die).

Dr. Meryl Nass: “Over 70% had an adverse reaction, 21% had a serious adverse event, and three of the children died. Because there was no control group, it’s unclear how either Gilead or the FDA determined that the drug benefited children, because there’s nothing to compare it to.”

What do you think?

Written by colinnew

Leave a Reply

Your email address will not be published. Required fields are marked *

Vaccine Study Of 23 Million Shows Risk Of ‘Heart Problems’ From Moderna Or Pfizer Jab


Amid Shanghai’s COVID-19 Surge, a Nursing Home Resident Was Sent to the Morgue While Still Alive